Atlas Trials

Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy

Clinical trial NCT02569723 · COMPLETED

Trial details

NCT number
NCT02569723
Sponsor
Edward Kim
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Colon Adenocarcinoma
Start date
2015-10-16
Primary completion
2018-04-20
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.